Global Small Interfering RNA (siRNA)-based Therapeutics Market Research Report 2026(Status and Outlook)
Small Interfering RNA (siRNA) drugs are a class of nucleic acid-based therapeutics that utilize short RNA molecules to silence or regulate the expression of specific genes. These drugs have the ability to interfere with the translation of messenger RNA (mRNA) into proteins, effectively "silencing" the gene associated with that mRNA. SiRNA-based therapies have the potential to treat a variety of diseases, particularly those with a genetic or RNA-based component.The Small Interfering RNA (siRNA) Drugs Market is driven by the transformative potential of siRNA-based therapies in silencing disease-associated genes, making them a promising approach for treating a wide range of diseases, including genetic disorders, viral infections, and various cancers. siRNA drugs work by selectively degrading or inhibiting the expression of specific genes, offering a highly targeted and personalized treatment option. As the understanding of genomics and RNA interference mechanisms advances, and the need for precision medicine grows, the demand for siRNA drugs continues to rise. Innovations in siRNA design, delivery systems, and gene-editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to overcome delivery barriers, ensure the stability and safety of siRNA therapeutics, and navigate regulatory complexities. Addressing off-target effects, optimizing pharmacokinetics, and managing the high cost of siRNA drug development are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to unlock the full therapeutic potential of siRNA drugs. Striking a balance between providing safe, effective, and accessible siRNA therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Small Interfering RNA (siRNA) Drugs Market.
The global Small Interfering RNA (siRNA)-based Therapeutics market size was estimated at USD 2047.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 27.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Small Interfering RNA (siRNA)-based Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Small Interfering RNA (siRNA)-based Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Small Interfering RNA (siRNA)-based Therapeutics market.
Global Small Interfering RNA (siRNA)-based Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Alnylam
Novartis
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Market Segmentation (by Type)
GIVLAARI
Onpattro
OXLUMO
AMVUTTRA
Leqvio
Market Segmentation (by Application)
AHP
hATTR
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Small Interfering RNA (siRNA)-based Therapeutics Market
Overview of the regional outlook of the Small Interfering RNA (siRNA)-based Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Small Interfering RNA (siRNA)-based Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Small Interfering RNA (siRNA)-based Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Small Interfering RNA (siRNA)-based Therapeutics market size was estimated at USD 2047.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 27.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Small Interfering RNA (siRNA)-based Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Small Interfering RNA (siRNA)-based Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Small Interfering RNA (siRNA)-based Therapeutics market.
Global Small Interfering RNA (siRNA)-based Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Alnylam
Novartis
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Market Segmentation (by Type)
GIVLAARI
Onpattro
OXLUMO
AMVUTTRA
Leqvio
Market Segmentation (by Application)
AHP
hATTR
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Small Interfering RNA (siRNA)-based Therapeutics Market
Overview of the regional outlook of the Small Interfering RNA (siRNA)-based Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Small Interfering RNA (siRNA)-based Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Small Interfering RNA (siRNA)-based Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Small Interfering RNA (siRNA)-based Therapeutics
1.2 Key Market Segments
1.2.1 Small Interfering RNA (siRNA)-based Therapeutics Segment by Type
1.2.2 Small Interfering RNA (siRNA)-based Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Small Interfering RNA (siRNA)-based Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Small Interfering RNA (siRNA)-based Therapeutics Product Life Cycle
3.3 Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Small Interfering RNA (siRNA)-based Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Small Interfering RNA (siRNA)-based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Small Interfering RNA (siRNA)-based Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Small Interfering RNA (siRNA)-based Therapeutics Market Competitive Situation and Trends
3.8.1 Small Interfering RNA (siRNA)-based Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Small Interfering RNA (siRNA)-based Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Small Interfering RNA (siRNA)-based Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Small Interfering RNA (siRNA)-based Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Small Interfering RNA (siRNA)-based Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Type (2020-2025)
6.4 Global Small Interfering RNA (siRNA)-based Therapeutics Price by Type (2020-2025)
7 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Sales by Application (2020-2025)
7.3 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Small Interfering RNA (siRNA)-based Therapeutics Sales Growth Rate by Application (2020-2025)
8 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET SALES BY REGION
8.1 Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Region
8.1.1 Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Region
8.1.2 Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Region
8.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region
8.2.1 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region
8.2.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Small Interfering RNA (siRNA)-based Therapeutics Sales by Country
8.3.2 North America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Small Interfering RNA (siRNA)-based Therapeutics Sales by Country
8.4.2 Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Sales by Region
8.5.2 Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Small Interfering RNA (siRNA)-based Therapeutics Sales by Country
8.6.2 South America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Sales by Region
8.7.2 Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Small Interfering RNA (siRNA)-based Therapeutics by Region(2020-2025)
9.2 Global Small Interfering RNA (siRNA)-based Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Small Interfering RNA (siRNA)-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Small Interfering RNA (siRNA)-based Therapeutics Production
9.4.1 North America Small Interfering RNA (siRNA)-based Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Small Interfering RNA (siRNA)-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Small Interfering RNA (siRNA)-based Therapeutics Production
9.5.1 Europe Small Interfering RNA (siRNA)-based Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Small Interfering RNA (siRNA)-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Small Interfering RNA (siRNA)-based Therapeutics Production (2020-2025)
9.6.1 Japan Small Interfering RNA (siRNA)-based Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Small Interfering RNA (siRNA)-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Small Interfering RNA (siRNA)-based Therapeutics Production (2020-2025)
9.7.1 China Small Interfering RNA (siRNA)-based Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Small Interfering RNA (siRNA)-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Alnylam
10.1.1 Alnylam Basic Information
10.1.2 Alnylam Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.1.3 Alnylam Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.1.4 Alnylam Business Overview
10.1.5 Alnylam SWOT Analysis
10.1.6 Alnylam Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.2.3 Novartis Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Sylentis
10.3.1 Sylentis Basic Information
10.3.2 Sylentis Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.3.3 Sylentis Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.3.4 Sylentis Business Overview
10.3.5 Sylentis SWOT Analysis
10.3.6 Sylentis Recent Developments
10.4 Arrowhead
10.4.1 Arrowhead Basic Information
10.4.2 Arrowhead Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.4.3 Arrowhead Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.4.4 Arrowhead Business Overview
10.4.5 Arrowhead Recent Developments
10.5 Silence Therapeutics
10.5.1 Silence Therapeutics Basic Information
10.5.2 Silence Therapeutics Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.5.3 Silence Therapeutics Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.5.4 Silence Therapeutics Business Overview
10.5.5 Silence Therapeutics Recent Developments
10.6 Dicerna
10.6.1 Dicerna Basic Information
10.6.2 Dicerna Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.6.3 Dicerna Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.6.4 Dicerna Business Overview
10.6.5 Dicerna Recent Developments
11 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast
11.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Region
11.2.4 South America Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Small Interfering RNA (siRNA)-based Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Small Interfering RNA (siRNA)-based Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Small Interfering RNA (siRNA)-based Therapeutics by Type (2026-2035)
12.1.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Small Interfering RNA (siRNA)-based Therapeutics by Type (2026-2035)
12.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Small Interfering RNA (siRNA)-based Therapeutics
1.2 Key Market Segments
1.2.1 Small Interfering RNA (siRNA)-based Therapeutics Segment by Type
1.2.2 Small Interfering RNA (siRNA)-based Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Small Interfering RNA (siRNA)-based Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Small Interfering RNA (siRNA)-based Therapeutics Product Life Cycle
3.3 Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Small Interfering RNA (siRNA)-based Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Small Interfering RNA (siRNA)-based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Small Interfering RNA (siRNA)-based Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Small Interfering RNA (siRNA)-based Therapeutics Market Competitive Situation and Trends
3.8.1 Small Interfering RNA (siRNA)-based Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Small Interfering RNA (siRNA)-based Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Small Interfering RNA (siRNA)-based Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Small Interfering RNA (siRNA)-based Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Small Interfering RNA (siRNA)-based Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Type (2020-2025)
6.4 Global Small Interfering RNA (siRNA)-based Therapeutics Price by Type (2020-2025)
7 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Sales by Application (2020-2025)
7.3 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Small Interfering RNA (siRNA)-based Therapeutics Sales Growth Rate by Application (2020-2025)
8 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET SALES BY REGION
8.1 Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Region
8.1.1 Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Region
8.1.2 Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Region
8.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region
8.2.1 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region
8.2.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Small Interfering RNA (siRNA)-based Therapeutics Sales by Country
8.3.2 North America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Small Interfering RNA (siRNA)-based Therapeutics Sales by Country
8.4.2 Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Sales by Region
8.5.2 Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Small Interfering RNA (siRNA)-based Therapeutics Sales by Country
8.6.2 South America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Sales by Region
8.7.2 Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Small Interfering RNA (siRNA)-based Therapeutics by Region(2020-2025)
9.2 Global Small Interfering RNA (siRNA)-based Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Small Interfering RNA (siRNA)-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Small Interfering RNA (siRNA)-based Therapeutics Production
9.4.1 North America Small Interfering RNA (siRNA)-based Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Small Interfering RNA (siRNA)-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Small Interfering RNA (siRNA)-based Therapeutics Production
9.5.1 Europe Small Interfering RNA (siRNA)-based Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Small Interfering RNA (siRNA)-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Small Interfering RNA (siRNA)-based Therapeutics Production (2020-2025)
9.6.1 Japan Small Interfering RNA (siRNA)-based Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Small Interfering RNA (siRNA)-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Small Interfering RNA (siRNA)-based Therapeutics Production (2020-2025)
9.7.1 China Small Interfering RNA (siRNA)-based Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Small Interfering RNA (siRNA)-based Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Alnylam
10.1.1 Alnylam Basic Information
10.1.2 Alnylam Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.1.3 Alnylam Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.1.4 Alnylam Business Overview
10.1.5 Alnylam SWOT Analysis
10.1.6 Alnylam Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.2.3 Novartis Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Sylentis
10.3.1 Sylentis Basic Information
10.3.2 Sylentis Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.3.3 Sylentis Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.3.4 Sylentis Business Overview
10.3.5 Sylentis SWOT Analysis
10.3.6 Sylentis Recent Developments
10.4 Arrowhead
10.4.1 Arrowhead Basic Information
10.4.2 Arrowhead Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.4.3 Arrowhead Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.4.4 Arrowhead Business Overview
10.4.5 Arrowhead Recent Developments
10.5 Silence Therapeutics
10.5.1 Silence Therapeutics Basic Information
10.5.2 Silence Therapeutics Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.5.3 Silence Therapeutics Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.5.4 Silence Therapeutics Business Overview
10.5.5 Silence Therapeutics Recent Developments
10.6 Dicerna
10.6.1 Dicerna Basic Information
10.6.2 Dicerna Small Interfering RNA (siRNA)-based Therapeutics Product Overview
10.6.3 Dicerna Small Interfering RNA (siRNA)-based Therapeutics Product Market Performance
10.6.4 Dicerna Business Overview
10.6.5 Dicerna Recent Developments
11 SMALL INTERFERING RNA (SIRNA)-BASED THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast
11.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Region
11.2.4 South America Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Small Interfering RNA (siRNA)-based Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Small Interfering RNA (siRNA)-based Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Small Interfering RNA (siRNA)-based Therapeutics by Type (2026-2035)
12.1.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Small Interfering RNA (siRNA)-based Therapeutics by Type (2026-2035)
12.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Type (M USD)
Table 4. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Application
Table 5. Small Interfering RNA (siRNA)-based Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Small Interfering RNA (siRNA)-based Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Small Interfering RNA (siRNA)-based Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA)-based Therapeutics as of 2025)
Table 11. Global Market Small Interfering RNA (siRNA)-based Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Small Interfering RNA (siRNA)-based Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Small Interfering RNA (siRNA)-based Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Type (K MT)
Table 27. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Type (M USD)
Table 28. Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) by Type (2020-2025)
Table 29. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Type (2020-2025)
Table 32. Global Small Interfering RNA (siRNA)-based Therapeutics Price (USD/KG) by Type (2020-2025)
Table 33. Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) by Application
Table 34. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Application
Table 35. Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Application (2020-2025) & (K MT)
Table 36. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Application (2020-2025)
Table 39. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Region (2020-2025) & (K MT)
Table 41. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region (2020-2025)
Table 44. North America Small Interfering RNA (siRNA)-based Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. North America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Small Interfering RNA (siRNA)-based Therapeutics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Small Interfering RNA (siRNA)-based Therapeutics Sales by Country (2020-2025) & (K MT)
Table 51. South America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Small Interfering RNA (siRNA)-based Therapeutics Production (K MT) by Region(2020-2025)
Table 55. Global Small Interfering RNA (siRNA)-based Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Small Interfering RNA (siRNA)-based Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Small Interfering RNA (siRNA)-based Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Small Interfering RNA (siRNA)-based Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Small Interfering RNA (siRNA)-based Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Small Interfering RNA (siRNA)-based Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Small Interfering RNA (siRNA)-based Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Alnylam Basic Information
Table 63. Alnylam Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 64. Alnylam Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Alnylam Business Overview
Table 66. Alnylam SWOT Analysis
Table 67. Alnylam Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 70. Novartis Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Sylentis Basic Information
Table 75. Sylentis Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 76. Sylentis Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sylentis Business Overview
Table 78. Sylentis SWOT Analysis
Table 79. Sylentis Recent Developments
Table 80. Arrowhead Basic Information
Table 81. Arrowhead Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 82. Arrowhead Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Arrowhead Business Overview
Table 84. Arrowhead Recent Developments
Table 85. Silence Therapeutics Basic Information
Table 86. Silence Therapeutics Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 87. Silence Therapeutics Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Silence Therapeutics Business Overview
Table 89. Silence Therapeutics Recent Developments
Table 90. Dicerna Basic Information
Table 91. Dicerna Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 92. Dicerna Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Dicerna Business Overview
Table 94. Dicerna Recent Developments
Table 95. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 96. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 97. North America Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 98. North America Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Europe Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 100. Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 102. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 104. South America Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 106. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Type (2026-2035) & (K MT)
Table 108. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 109. Global Small Interfering RNA (siRNA)-based Therapeutics Price Forecast by Type (2026-2035) & (USD/KG)
Table 110. Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) Forecast by Application (2026-2035)
Table 111. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Type (M USD)
Table 4. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Application
Table 5. Small Interfering RNA (siRNA)-based Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Small Interfering RNA (siRNA)-based Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Small Interfering RNA (siRNA)-based Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA)-based Therapeutics as of 2025)
Table 11. Global Market Small Interfering RNA (siRNA)-based Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Small Interfering RNA (siRNA)-based Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Small Interfering RNA (siRNA)-based Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Type (K MT)
Table 27. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Type (M USD)
Table 28. Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) by Type (2020-2025)
Table 29. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Type (2020-2025)
Table 32. Global Small Interfering RNA (siRNA)-based Therapeutics Price (USD/KG) by Type (2020-2025)
Table 33. Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) by Application
Table 34. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Application
Table 35. Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Application (2020-2025) & (K MT)
Table 36. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Application (2020-2025)
Table 39. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Small Interfering RNA (siRNA)-based Therapeutics Sales by Region (2020-2025) & (K MT)
Table 41. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region (2020-2025)
Table 44. North America Small Interfering RNA (siRNA)-based Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. North America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Small Interfering RNA (siRNA)-based Therapeutics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Small Interfering RNA (siRNA)-based Therapeutics Sales by Country (2020-2025) & (K MT)
Table 51. South America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Small Interfering RNA (siRNA)-based Therapeutics Production (K MT) by Region(2020-2025)
Table 55. Global Small Interfering RNA (siRNA)-based Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Small Interfering RNA (siRNA)-based Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Small Interfering RNA (siRNA)-based Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Small Interfering RNA (siRNA)-based Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Small Interfering RNA (siRNA)-based Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Small Interfering RNA (siRNA)-based Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Small Interfering RNA (siRNA)-based Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Alnylam Basic Information
Table 63. Alnylam Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 64. Alnylam Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Alnylam Business Overview
Table 66. Alnylam SWOT Analysis
Table 67. Alnylam Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 70. Novartis Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Sylentis Basic Information
Table 75. Sylentis Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 76. Sylentis Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sylentis Business Overview
Table 78. Sylentis SWOT Analysis
Table 79. Sylentis Recent Developments
Table 80. Arrowhead Basic Information
Table 81. Arrowhead Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 82. Arrowhead Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Arrowhead Business Overview
Table 84. Arrowhead Recent Developments
Table 85. Silence Therapeutics Basic Information
Table 86. Silence Therapeutics Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 87. Silence Therapeutics Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Silence Therapeutics Business Overview
Table 89. Silence Therapeutics Recent Developments
Table 90. Dicerna Basic Information
Table 91. Dicerna Small Interfering RNA (siRNA)-based Therapeutics Product Overview
Table 92. Dicerna Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Dicerna Business Overview
Table 94. Dicerna Recent Developments
Table 95. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 96. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 97. North America Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 98. North America Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Europe Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 100. Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 102. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 104. South America Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 106. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Type (2026-2035) & (K MT)
Table 108. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 109. Global Small Interfering RNA (siRNA)-based Therapeutics Price Forecast by Type (2026-2035) & (USD/KG)
Table 110. Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) Forecast by Application (2026-2035)
Table 111. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Small Interfering RNA (siRNA)-based Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Small Interfering RNA (siRNA)-based Therapeutics Product Life Cycle
Figure 13. Small Interfering RNA (siRNA)-based Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Small Interfering RNA (siRNA)-based Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Small Interfering RNA (siRNA)-based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Small Interfering RNA (siRNA)-based Therapeutics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Small Interfering RNA (siRNA)-based Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Small Interfering RNA (siRNA)-based Therapeutics
Figure 19. Global Small Interfering RNA (siRNA)-based Therapeutics Market PEST Analysis
Figure 20. Global Small Interfering RNA (siRNA)-based Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Type
Figure 27. Sales Market Share of Small Interfering RNA (siRNA)-based Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Small Interfering RNA (siRNA)-based Therapeutics by Type in 2025
Figure 29. Market Share of Small Interfering RNA (siRNA)-based Therapeutics by Type (2020-2025)
Figure 30. Market Share of Small Interfering RNA (siRNA)-based Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Application
Figure 33. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Application in 2025
Figure 37. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country in 2024
Figure 45. U.S. Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Small Interfering RNA (siRNA)-based Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Small Interfering RNA (siRNA)-based Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country in 2024
Figure 55. Germany Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region in 2024
Figure 68. China Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country in 2024
Figure 82. Brazil Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Small Interfering RNA (siRNA)-based Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Small Interfering RNA (siRNA)-based Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Small Interfering RNA (siRNA)-based Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Small Interfering RNA (siRNA)-based Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Small Interfering RNA (siRNA)-based Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Small Interfering RNA (siRNA)-based Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Small Interfering RNA (siRNA)-based Therapeutics Product Life Cycle
Figure 13. Small Interfering RNA (siRNA)-based Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Small Interfering RNA (siRNA)-based Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Small Interfering RNA (siRNA)-based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Small Interfering RNA (siRNA)-based Therapeutics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Small Interfering RNA (siRNA)-based Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Small Interfering RNA (siRNA)-based Therapeutics
Figure 19. Global Small Interfering RNA (siRNA)-based Therapeutics Market PEST Analysis
Figure 20. Global Small Interfering RNA (siRNA)-based Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Type
Figure 27. Sales Market Share of Small Interfering RNA (siRNA)-based Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Small Interfering RNA (siRNA)-based Therapeutics by Type in 2025
Figure 29. Market Share of Small Interfering RNA (siRNA)-based Therapeutics by Type (2020-2025)
Figure 30. Market Share of Small Interfering RNA (siRNA)-based Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Application
Figure 33. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share by Application in 2025
Figure 37. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country in 2024
Figure 45. U.S. Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Small Interfering RNA (siRNA)-based Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Small Interfering RNA (siRNA)-based Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Small Interfering RNA (siRNA)-based Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Small Interfering RNA (siRNA)-based Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country in 2024
Figure 55. Germany Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region in 2024
Figure 68. China Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Small Interfering RNA (siRNA)-based Therapeutics Market Size by Country in 2024
Figure 82. Brazil Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Small Interfering RNA (siRNA)-based Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Small Interfering RNA (siRNA)-based Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Small Interfering RNA (siRNA)-based Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Small Interfering RNA (siRNA)-based Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Small Interfering RNA (siRNA)-based Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Small Interfering RNA (siRNA)-based Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Small Interfering RNA (siRNA)-based Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Small Interfering RNA (siRNA)-based Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Small Interfering RNA (siRNA)-based Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Small Interfering RNA (siRNA)-based Therapeutics Market Share Forecast by Application (2026-2035)
